Annals of Oncology

in this issue

in this issue
Ann Oncol 2009 20: 195; doi:10.1093/annonc/mdn790 [Extract] [Full Text] [PDF] [Request Permissions]  

editorials

C. Massard, A. Chauchereau, and K. Fizazi

The quest for the ‘bony Grail’ of detecting circulating tumour cells in patients with prostate cancer
Ann Oncol 2009 20: 197-199; doi:10.1093/annonc/mdp017 [Extract] [Full Text] [PDF] [Request Permissions]  

B. I. Lévy

Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor
Ann Oncol 2009 20: 200-203; doi:10.1093/annonc/mdp018 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews

Get checked abstract P. Vineis and W. Xun

The emerging epidemic of environmental cancers in developing countries
Annals of Oncology Advance Access published on October 14, 2008
Ann Oncol 2009 20: 205-212; doi:10.1093/annonc/mdn596 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract M. A. Pantaleo, M. Nannini, A. Maleddu, S. Fanti, C. Nanni, S. Boschi, F. Lodi, G. Nicoletti, L. Landuzzi, P. L. Lollini, and G. Biasco

Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer
Annals of Oncology Advance Access published on October 7, 2008
Ann Oncol 2009 20: 213-226; doi:10.1093/annonc/mdn625 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles

gastrointestinal tumors

Get checked abstract M. Scartozzi, E. Galizia, S. Chiorrini, R. Giampieri, R. Berardi, C. Pierantoni, and S. Cascinu

Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab
Annals of Oncology Advance Access published on October 7, 2008
Ann Oncol 2009 20: 227-230; doi:10.1093/annonc/mdn637 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract E. Bollschweiler, R. Metzger, U. Drebber, S. Baldus, D. Vallböhmer, M. Kocher, and A. H. Hölscher

Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis
Annals of Oncology Advance Access published on October 3, 2008
Ann Oncol 2009 20: 231-238; doi:10.1093/annonc/mdn622 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract T. Uwagawa, T. Misawa, T. Sakamoto, R. Ito, T. Gocho, H. Shiba, S. Wakiyama, S. Hirohara, S. Sadaoka, and K. Yanaga

A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer
Annals of Oncology Advance Access published on October 3, 2008
Ann Oncol 2009 20: 239-243; doi:10.1093/annonc/mdn640 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract D. Cunningham, B. Sirohi, A. Pluzanska, B. Utracka-Hutka, J. Zaluski, R. Glynne-Jones, P. Koralewski, J. Bridgewater, P. Mainwaring, H. Wasan, J.-Y. Wang, C. Szczylik, P. Clingan, R. T. T. Chan, I. Tabah-Fisch, and J. Cassidy

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
Annals of Oncology Advance Access published on October 14, 2008
Ann Oncol 2009 20: 244-250; doi:10.1093/annonc/mdn638 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract E. Aranda, M. Valladares, M. Martinez-Villacampa, M. Benavides, A. Gomez, B. Massutti, E. Marcuello, M. Constenla, J. C. Cámara, A. Carrato, R. Dueñas, M. Reboredo, M. Navarro, and E. Díaz-Rubio

Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study
Annals of Oncology Advance Access published on August 20, 2008
Ann Oncol 2009 20: 251-257; doi:10.1093/annonc/mdn557 [Abstract] [Full Text] [PDF] [Request Permissions]  

breast cancer

Get checked abstract M. Schmidt, A. Victor, D. Bratzel, D. Boehm, C. Cotarelo, A. Lebrecht, W. Siggelkow, J. G. Hengstler, A. Elsäßer, M. Gehrmann, H. -A. Lehr, H. Koelbl, G. von Minckwitz, N. Harbeck, and C. Thomssen

Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer—comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial
Annals of Oncology Advance Access published on September 29, 2008
Ann Oncol 2009 20: 258-264; doi:10.1093/annonc/mdn590 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract C. Andreetta, C. Puppin, A. Minisini, F. Valent, E. Pegolo, G. Damante, C. Di Loreto, S. Pizzolitto, M. Pandolfi, G. Fasola, A. Piga, and F. Puglisi

Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer
Annals of Oncology Advance Access published on September 2, 2008
Ann Oncol 2009 20: 265-271; doi:10.1093/annonc/mdn592 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract H. Chang, S. Y. Rha, H. -C. Jeung, C. -K. Im, J. B. Ahn, W. S. Kwon, N. C. Yoo, J. K. Roh, and H. C. Chung

Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients
Annals of Oncology Advance Access published on October 3, 2008
Ann Oncol 2009 20: 272-277; doi:10.1093/annonc/mdn624 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract N. Maniadakis, U. Dafni, V. Fragoulakis, I. Grimani, E. Galani, A. Fragkoulidi, and G. Fountzilas

Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial
Annals of Oncology Advance Access published on October 7, 2008
Ann Oncol 2009 20: 278-285; doi:10.1093/annonc/mdn634 [Abstract] [Full Text] [PDF] [Request Permissions]  

gynecologic tumors

Get checked abstract H. Oksefjell, B. Sandstad, and C. Tropé

The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer
Annals of Oncology Advance Access published on August 25, 2008
Ann Oncol 2009 20: 286-293; doi:10.1093/annonc/mdn591 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract A. Prat, M. Parera, B. Adamo, S. Peralta, M. A. Perez-Benavente, A. Garcia, A. Gil-Moreno, J. M. Martinez-Palones, J. Baselga, and J. M. del Campo

Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels
Annals of Oncology Advance Access published on September 26, 2008
Ann Oncol 2009 20: 294-297; doi:10.1093/annonc/mdn601 [Abstract] [Full Text] [PDF] [Request Permissions]  

lung cancer

Get checked abstract F. Cappuzzo, P. A. Jänne, M. Skokan, G. Finocchiaro, E. Rossi, C. Ligorio, P. A. Zucali, L. Terracciano, L. Toschi, M. Roncalli, A. Destro, M. Incarbone, M. Alloisio, A. Santoro, and M. Varella-Garcia

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients
Annals of Oncology Advance Access published on October 3, 2008
Ann Oncol 2009 20: 298-304; doi:10.1093/annonc/mdn635 [Abstract] [Full Text] [PDF] [Request Permissions]  

urogenital tumors

Get checked abstract D. J. Gallagher, M. I. Milowsky, N. Ishill, A. Trout, M. G. Boyle, J. Riches, M. Fleisher, and D. F. Bajorin

Detection of circulating tumor cells in patients with urothelial cancer
Annals of Oncology Advance Access published on October 3, 2008
Ann Oncol 2009 20: 305-308; doi:10.1093/annonc/mdn627 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies

Get checked abstract H. S. Han, M. P. Escalón, B. Hsiao, A. Serafini, and I. S. Lossos

High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens
Annals of Oncology Advance Access published on October 7, 2008
Ann Oncol 2009 20: 309-318; doi:10.1093/annonc/mdn629 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract G. Illerhaus, R. Marks, F. Müller, G. Ihorst, F. Feuerhake, M. Deckert, C. Ostertag, and J. Finke

High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study
Annals of Oncology Advance Access published on October 26, 2008
Ann Oncol 2009 20: 319-325; doi:10.1093/annonc/mdn628 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract J. Valencak, F. Weihsengruber, K. Rappersberger, F. Trautinger, A. Chott, B. Streubel, L. Muellauer, M. Der-Petrossian, C. Jonak, M. Binder, and M. Raderer

Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients
Annals of Oncology Advance Access published on October 3, 2008
Ann Oncol 2009 20: 326-330; doi:10.1093/annonc/mdn636 [Abstract] [Full Text] [PDF] [Request Permissions]  

quality of life/supportive care/palliative care

Get checked abstract T. Van den Wyngaert, T. Claeys, M. T. Huizing, J. B. Vermorken, and E. Fossion

Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome
Annals of Oncology Advance Access published on October 26, 2008
Ann Oncol 2009 20: 331-336; doi:10.1093/annonc/mdn630 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract J. P. M. Derikx, N. M. A. Blijlevens, J. P. Donnelly, H. Fujii, T. Kanda, A. A. van Bijnen, E. Heineman, and W. A. Buurman

Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients
Annals of Oncology Advance Access published on August 25, 2008
Ann Oncol 2009 20: 337-342; doi:10.1093/annonc/mdn579 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract S. T. Tang, S.-C. Wu, Y.-N. Hung, E.-W. Huang, J.-S. Chen, and T.-W. Liu

Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000–2006
Annals of Oncology Advance Access published on September 2, 2008
Ann Oncol 2009 20: 343-348; doi:10.1093/annonc/mdn602 [Abstract] [Full Text] [PDF] [Request Permissions]  

oncology practice

Get checked abstract E. Galligioni, F. Berloffa, O. Caffo, G. Tonazzolli, G. Ambrosini, F. Valduga, C. Eccher, A. Ferro, and S. Forti

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience
Annals of Oncology Advance Access published on August 20, 2008
Ann Oncol 2009 20: 349-352; doi:10.1093/annonc/mdn567 [Abstract] [Full Text] [PDF] [Request Permissions]  

epidemiology

Get checked abstract J. Polesel, A. Zucchetto, M. Montella, L. Dal Maso, A. Crispo, C. La Vecchia, D. Serraino, S. Franceschi, and R. Talamini

The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
Annals of Oncology Advance Access published on August 22, 2008
Ann Oncol 2009 20: 353-357; doi:10.1093/annonc/mdn565 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract E. R. Koomen, A. Joosse, R. M. C. Herings, M. K. Casparie, H. J. Guchelaar, and T. Nijsten

Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study
Annals of Oncology Advance Access published on August 25, 2008
Ann Oncol 2009 20: 358-364; doi:10.1093/annonc/mdn589 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract J. C. van Gaal, E. Bastiaannet, M. Schaapveld, R. Otter, J. C. Kluin-Nelemans, E. S. J. M. de Bont, and W. T. A. van der Graaf

Cancer in adolescents and young adults in north Netherlands (1989–2003): increased incidence, stable survival and high incidence of second primary tumours
Annals of Oncology Advance Access published on August 25, 2008
Ann Oncol 2009 20: 365-373; doi:10.1093/annonc/mdn588 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract M. Rossi, J. K. McLaughlin, P. Lagiou, C. Bosetti, R. Talamini, L. Lipworth, A. Giacosa, M. Montella, S. Franceschi, E. Negri, and C. La Vecchia

Vitamin D intake and breast cancer risk: a case–control study in Italy
Annals of Oncology Advance Access published on August 18, 2008
Ann Oncol 2009 20: 374-378; doi:10.1093/annonc/mdn550 [Abstract] [Full Text] [PDF] [Request Permissions]  

clinical trials

Get checked abstract O. Berger, B. H. Grønberg, K. Sand, S. Kaasa, and J. H. Loge

The length of consent documents in oncological trials is doubled in twenty years
Annals of Oncology Advance Access published on October 15, 2008
Ann Oncol 2009 20: 379-385; doi:10.1093/annonc/mdn623 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor

U. Basso, A. Brunello, A. Bertuzzi, and A. Santoro

Sorafenib is active on lung metastases from synovial sarcoma
Ann Oncol 2009 20: 386-387; doi:10.1093/annonc/mdn685 [Extract] [Full Text] [PDF] [Request Permissions]  

S. Yao, B. Xu, F. Ma, Y. Liao, and Y. Fan

Breast cancer in women younger than 25: clinicopathological features and prognostic factors
Ann Oncol 2009 20: 387-389; doi:10.1093/annonc/mdn711 [Extract] [Full Text] [PDF] [Request Permissions]  

M. P. Brizzi, C. M. Sculli, F. Ragni, F. Porpiglia, M. Tampellini, G. Gorzegno, A. M. Priola, L. Dogliotti, and A. Berruti

Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma
Annals of Oncology Advance Access published on January 19, 2009
Ann Oncol 2009 20: 389-390; doi:10.1093/annonc/mdn720 [Extract] [Full Text] [PDF] [Request Permissions]  

S. J. Kim, K. Kim, B. S. Kim, C. Suh, J. Huh, Y. H. Ko, and W. S. Kim

Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study
Ann Oncol 2009 20: 390-392; doi:10.1093/annonc/mdn726 [Extract] [Full Text] [PDF] [Request Permissions]  

M. Reckova, M. Kakalejcik, and J. Beniak

Treatment of hemodialyzed patient with sunitinib
Annals of Oncology Advance Access published on January 8, 2009
Ann Oncol 2009 20: 392-393; doi:10.1093/annonc/mdn734 [Extract] [Full Text] [PDF] [Request Permissions]  

P. Bono, H. Elfving, T. Utriainen, P. Österlund, T. Saarto, T. Alanko, and H. Joensuu

Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma
Ann Oncol 2009 20: 393-394; doi:10.1093/annonc/mdn729 [Extract] [Full Text] [PDF] [Request Permissions]  

B. Bitik, Y. Kalpakci, E. Altan, E. Dogan, and K. Altundag

Successful treatment of primary duodenal carcinoma with bilateral adrenal metastases with docetaxel–cisplatin–5-fluorouracil regimen
Ann Oncol 2009 20: 394-395; doi:10.1093/annonc/mdn741 [Extract] [Full Text] [PDF] [Request Permissions]  

P. Bradbury, R. Meyer, J. Pater, D. Tu, L. Seymour, L. Shepherd, and E. Eisenhauer

Stopping a trial early in oncology: for patients or for industry?
Annals of Oncology Advance Access published on January 15, 2009
Ann Oncol 2009 20: 395-396; doi:10.1093/annonc/mdn753 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.